Published: January 2017
Roots Analysis has announced the addition of the “T-Cell Immunotherapy Market, 2017-2030 (2nd edition)” report to its portfolio. The report features an extensive study of the current market landscape of T-cell immunotherapies. It is worth highlighting that the report primarily focuses on the three major emerging classes of T-cell therapies, namely CAR-T, TCR and TIL.
Shadali Singh, the principal analyst, said, “Academic institutions continue to lead the innovation in this domain; universities and research institutes have made significant contributions in the design and development of novel T-cell based therapies. Post the establishment of initial proof-of-concept, many institutes have entered into collaborations with industry stakeholders to advance the clinical development of promising therapy candidates.
Singh further stated, “Amidst several challenges, including the complexities associated with manufacturing cell-based products and competition from existing drug classes, therapy developers have progressed significantly in search of innovative solutions. Contract manufacturing organizations with advanced capabilities have emerged as a valuable asset, providing manufacturing services for T-cell based therapies.”
One of the key objectives of the report was to identify the primary growth drivers and estimate the future size of the market. Amongst other things, the report covers:
The opinions and insights presented in this study were influenced by discussions conducted with experts in this field. These included contributions from the following individuals:
In addition, the report highlights the involvement of non-industry players, such as the Baylor College of Medicine, Chinese PLA GeneralHospital, City of Hope Medical Center, Fred Hutchinson Cancer Research Center, MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Nantes University Hospital, National Cancer Institute and Netherlands Cancer Institute.
For additional details, please visit
About Roots Analysis
Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at email@example.com
We are your partners with no equity
We fit in your budget
We love what we do
Chance to prove ourselves
Best in class quality of work
Most trusted consulting partner in the industry
SUBSCRIBE TO INDUSTRY UPDATES